Transcriptional regulation of metastatic [Id] entity by KLF17
MP Iwanicki, JS Brugge - Genome biology, 2009 - Springer
Transcriptional regulation of metastatic [Id]entity by KLF17 | Genome Biology Skip to main
content SpringerLink Account Menu Find a journal Publish with us Track your research Search …
content SpringerLink Account Menu Find a journal Publish with us Track your research Search …
CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment
X Li, W Xu - Oncology reports, 2019 - spandidos-publications.com
Impaired antitumor immunity or induced immunosuppression in the tumor microenvironment
contributes significantly to tumor progression and resistance to immunotherapy. It is …
contributes significantly to tumor progression and resistance to immunotherapy. It is …
KRAS Mutant Tumor Subpopulations can Subvert Durable Responses to Personalized Cancer Treatments
BL Parsons, MB Myers - Personalized Medicine, 2013 - Taylor & Francis
KRAS mutations in colorectal and lung cancers predict failure to respond to therapies that
target the EGFR. Significant percentages of patients with KRAS wild-type tumors also fail to …
target the EGFR. Significant percentages of patients with KRAS wild-type tumors also fail to …
Evaluation of nitroreductase activity in nasopharyngeal carcinoma progression by an activatable two-photon fluorescent probe
Nasopharyngeal carcinoma (NPC) originating from the epithelium cells is the most common
malignant tumor of the head and neck. Small-molecule fluorescent probes for early …
malignant tumor of the head and neck. Small-molecule fluorescent probes for early …
Radiolabeled probes targeting hypoxia‐inducible factor‐1‐active tumor microenvironments
M Ueda, H Saji - The Scientific World Journal, 2014 - Wiley Online Library
Because tumor cells grow rapidly and randomly, hypoxic regions arise from the lack of
oxygen supply in solid tumors. Hypoxic regions in tumors are known to be resistant to …
oxygen supply in solid tumors. Hypoxic regions in tumors are known to be resistant to …
Fluorine-18 click radiosynthesis and microPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX
L Jia, X Li, D Cheng, L Zhang - Bioorganic & Medicinal Chemistry, 2019 - Elsevier
Abstract Carbonic anhydrase IX (CA IX) is the first carbonic anhydrase found to be
associated with cancer that is over-expressed in a variety of human solid tumors. As a …
associated with cancer that is over-expressed in a variety of human solid tumors. As a …
Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1α
M Ueda, T Kudo, Y Kuge, T Mukai, S Tanaka… - European journal of …, 2010 - Springer
Abstract Purpose Hypoxia-inducible factor-1 (HIF-1) plays an important role in malignant
tumour progression. For the imaging of HIF-1-active tumours, we previously developed a …
tumour progression. For the imaging of HIF-1-active tumours, we previously developed a …
Development of an oxygen-sensitive degradable peptide probe for the imaging of hypoxia-inducible factor-1-active regions in tumors
M Ueda, K Ogawa, A Miyano, M Ono… - Molecular imaging and …, 2013 - Springer
Purpose We aimed to develop a radiolabeled peptide probe for the imaging of hypoxia-
inducible factor-1 (HIF-1)-active tumors. Procedures We synthesized the peptide probes that …
inducible factor-1 (HIF-1)-active tumors. Procedures We synthesized the peptide probes that …
Evaluation of [125I]IPOS as a molecular imaging probe for hypoxia‐inducible factor‐1‐active regions in a tumor: Comparison among single‐photon emission …
M Ueda, T Kudo, Y Mutou, IO Umeda, A Miyano… - Cancer …, 2011 - Wiley Online Library
To image hypoxia‐inducible factor‐1 (HIF‐1)‐active tumors, we previously developed a
chimeric protein probe ([123/125I] IPOS) that is degraded in the same manner as HIF‐1α …
chimeric protein probe ([123/125I] IPOS) that is degraded in the same manner as HIF‐1α …